Search

Your search keyword '"Tjan-Heijnen, Vivianne"' showing total 835 results

Search Constraints

Start Over You searched for: Author "Tjan-Heijnen, Vivianne" Remove constraint Author: "Tjan-Heijnen, Vivianne"
835 results on '"Tjan-Heijnen, Vivianne"'

Search Results

1. Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial

2. Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

4. The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry

5. Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional study

6. Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

7. PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial

8. Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

10. Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry

12. Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study

14. Pervasive chromosomal instability and karyotype order in tumour evolution

15. Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial

16. Oncological care organisation during COVID-19 outbreak.

18. De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)

19. The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

20. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study

23. Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer

24. Diagnostic accuracy of cross-sectional and endoscopic imaging in ampullary tumours: systematic review

25. A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands

26. Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

30. Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making

31. Continuity of care for patients with de novo metastatic cancer during the COVID‐19 pandemic: A population‐based observational study.

33. Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study

36. Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry

37. The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry

38. Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer

39. Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

41. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience

42. Pan-cancer whole-genome analyses of metastatic solid tumours

43. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies

47. Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer.

48. Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study.

49. Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

50. The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

Catalog

Books, media, physical & digital resources